Cynthia S Classen, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr, Suite 101, Castle Pines, CO 80108 Phone: 303-805-5156 Fax: 303-805-5157 |
Dr. Brian Michael Oase, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr Ste 101, Castle Pines, CO 80108 Phone: 303-805-5156 |
Katherine Heugel, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr Ste 101, Castle Pines, CO 80108 Phone: 303-805-5156 Fax: 303-805-5157 |
Castle Pines Foot And Ankle Clinic, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 7505 Village Square Dr, Ste 101, Castle Pines, CO 80108 Phone: 303-805-5156 Fax: 303-805-5157 |
Daniel Zay Clymer, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr Ste 101, Castle Pines, CO 80108 Phone: 303-805-5156 |
Dr. Paul Fawson, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr, Suite 101, Castle Pines, CO 80108 Phone: 303-805-5156 Fax: 303-805-5157 |
Deann Hofer, D.P.M. Podiatrist - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr Ste 101, Castle Pines, CO 80108 Phone: 303-805-5156 Fax: 303-805-5157 |
Meghan Kathleen Morgan, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr Ste 101, Castle Pines, CO 80108 Phone: 033-805-5156 Fax: 303-805-5157 |
Patrick Thompson, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 7505 Village Square Dr Ste 101, Castle Pines, CO 80108 Phone: 303-805-5156 |
News Archive
Semafore Pharmaceuticals today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,745,485 entitled "Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways." This patent covers methods of inhibiting the spread of cancer in patients using phosphoinositide-3-kinase (PI3K) inhibitors alone or in combination with chemotherapeutic agents.
The research group led by Dr. Koji Hasegawa, Director of the Translational Research Division at the National Hospital Organization Kyoto Medical Center and Dr. Tatsuya Morimoto, Professor at the Molecular Medicine School of Pharmaceutical Sciences, University of Shizuoka, announced today based on the recent human clinical trials, that Theracurmin has continuously shown positive impact on human diastolic functions.
With just days to go until Election Day, the Romney campaign sees possibilities to win in Pennsylvania, Michigan and Minnesota, while pro-Obama groups launch new ads about Medicare and women's health.
Roche announced today the introduction of a new protein melting application for its high-throughput, real-time PCR LightCycler 1536 instrument. The fully automated platform now allows life science researchers to perform thermal shift assays (TSAs) in 1536-well applications quickly and consistently.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information regarding a randomized Phase III clinical trial of DacogenĀ® (decitabine) for Injection in elderly patients with acute myeloid leukemia (AML). The comparator in this trial was low-dose cytarabine, a chemotherapy agent, or supportive care.
› Verified 3 days ago